Europe • Frankfurt Stock Exchange • FRA:IUI1 • US46120E6023
The current stock price of IUI1.DE is 423.8 EUR. In the past month the price decreased by -12.22%. In the past year, price decreased by -25.43%.
ChartMill assigns a fundamental rating of 6 / 10 to IUI1.DE. IUI1.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months IUI1.DE reported a non-GAAP Earnings per Share(EPS) of 7.54. The EPS increased by 21.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.58% | ||
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| Debt/Equity | 0 |
40 analysts have analysed IUI1.DE and the average price target is 531.45 EUR. This implies a price increase of 25.4% is expected in the next year compared to the current price of 423.8.
For the next year, analysts expect an EPS growth of 11.25% and a revenue growth 15.2% for IUI1.DE
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.28 | 111.57B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.75 | 108.30B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.68 | 47.66B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.73 | 23.84B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.52 | 23.55B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.46 | 23.46B | ||
| BIM.PA | BIOMERIEUX | 24.97 | 11.41B | ||
| DIA.MI | DIASORIN SPA | 21.92 | 4.06B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 130.16 | 3.91B | ||
| 1AFX.MI | CARL ZEISS MEDITEC AG - BR | 17.45 | 2.51B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 17.34 | 2.50B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 13.74 | 1.66B |
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
INTUITIVE SURGICAL INC
1020 Kifer Road
Sunnyvale CALIFORNIA US
Employees: 15638
Phone: 14085232100
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
The current stock price of IUI1.DE is 423.8 EUR. The price decreased by -0.12% in the last trading session.
IUI1.DE does not pay a dividend.
IUI1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
IUI1.DE stock is listed on the Frankfurt Stock Exchange exchange.
The Revenue of INTUITIVE SURGICAL INC (IUI1.DE) is expected to grow by 15.2% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.